Halaman 1 dari 38 hasil
FIELD OF THE INVENTION
The present invention relates to fluorescent silica-based nanoparticles, and methods of using the nanoparticles to detect, diagnose, or treat diseases such as cancer.
BACKGROUND OF THE INVENTION
Early tumor detection and treatment selection is paramount to achieving
FIELD OF THE INVENTION
In one aspect, the invention provides novel monodisperse, colloidally-stable, torroidal mesoporous silica nanoparticles (TMSNPs) which are synthesized from ellipsoid-shaped mesoporous silica nanoparticles (MSNPs) which are prepared using an ammonia base-catalyzed method under
FIELD OF THE INVENTION
The present invention relates to fluorescent silica-based nanoparticles, and methods of using the nanoparticles to detect, diagnose, or treat diseases such as cancer.
BACKGROUND OF THE INVENTION
Early tumor detection and treatment selection is paramount to achieving
FIELD OF THE INVENTION
The present invention relates to fluorescent silica-based nanoparticles, and methods of using the nanoparticles to detect, diagnose, or treat diseases such as cancer.
BACKGROUND OF THE INVENTION
Early tumor detection and treatment selection is paramount to achieving
FIELD OF THE INVENTION
The present invention relates to fluorescent silica-based nanoparticles, and methods of using the nanoparticles to detect, diagnose, or treat diseases such as cancer.
BACKGROUND OF THE INVENTION
Early tumor detection and treatment selection is paramount to achieving
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted electronically in ASCII format and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Nov. 7, 2017, is named 2003080-1330_SL.txt and is 2,007 bytes in size.
FIELD OF THE
FIELD OF THE INVENTION
The present invention discloses a novel method to isolate a natural flavonoid; inoscavin A indicated in formula 1, from mushroom F. fastuosus, having promising antiprolifertive activity on rhabdomyosarcoma and thereby communicates its application to use it as a medicinal
BACKGROUND OF THE INVENTION
In tumors, not only there are cancer cells of different phenotypes, but there are also normal cells (e.g., fibroblasts, myoblasts, endothelial cells, epithelial cells, and stromal cells). This makes detecting or isolating cancer cells from tumor specimens and biopsies an
FIELD OF THE INVENTION
This invention relates to biocompatible injectable compositions.
BACKGROUND OF THE INVENTION
Vaccines that require ex vivo manipulation of cells, such as most cell based therapy, lead to poor lymph node homing and limited efficiency.
SUMMARY OF THE INVENTION
The invention
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a novel anti-cancer compound identified in mycelium of Antrodia camphorata, the methods of cultivation, and applications of the said compound. To be more specific, the extracted compound is a bioactive anti-cancer
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to an immunopotentiator having an anti-tumor activity, which agent is obtaind from marine chlorellas and useful as foods, drugs, pesticides, reagents, etc.
2. Related Art Statement
A large number of anti-tumor active
BACKGROUND OF THE INVENTION
The present invention relates generally to bioanalytical testing procedures to aid in the diagnosis of cancer and to evaluate therapeutic treatment by antineoplastons. More particularly, the invention relates to a quantitative determination of antineoplaston levels in
CROSS-REFERENCE TO RELATED APPLICATIONS
None.
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
None.
REFERENCE TO SEQUENCE LISTING
None.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is directed to the isolation, purification and structural identification
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is directed to the isolation, purification and structural identification of the bioactive component of water extracts of Cat's Claw (Uncaria species). The bioactive component is identified as quinic acid lactone. The present
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is directed to the isolation, purification and structural identification of the bioactive component of water extracts of Cat's Claw (Uncaria species). The bioactive component previously was identified in vitro as quinic acid